selected publications

• letter

  • Current bioequivalence criteria are adequate for oral cyclosporin A formulations [1].  Therapeutic Drug Monitoring. 722-723. 1998-01-01

• article

  • Oral Ciprofloxacin Pharmacokinetics in Healthy Mexican Volunteers and Other Populations: Is There Interethnic Variability?.  Archives of Medical Research.  51:268-277. 2020-01-01
  • Decreased cyclosporine exposure during the remission of nephrotic syndrome.  Pediatric Nephrology.  22:84-90. 2007-01-01
  • Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats.  Canadian Journal of Physiology and Pharmacology.  85:502-506. 2007-01-01
  • L-arginine reverses alterations in drug disposition induced by spinal cord injury by increasing hepatic blood flow.  Journal of Neurotrauma.  24:1855-1862. 2007-01-01
  • Isobolographic analysis of the dual-site synergism in the antinociceptive response of tramadol in the formalin test in rats.  Life Sciences.  79:2275-2282. 2006-01-01
  • In vitro antigiardial activity of IRE-6A and IRE-7B, two ethyl-phenylcarbamate derivatives 2003-01-01
  • Ketorolac pharmacokinetics in experimental cirrhosis by bile duct ligation in the rat..  Annals of hepatology : official journal of the Mexican Association of Hepatology.  2:175-181. 2003-01-01
  • Synergistic effects between codeine and diclofenac after local, spinal and systemic administration.  Pharmacology Biochemistry and Behavior.  76:463-471. 2003-01-01
  • Pharmacokinetic/pharmacodynamic modeling of antipyretic and anti-inflammatory effects of naproxen in the rat.  Journal of Pharmacology and Experimental Therapeutics.  297:198-205. 2001-01-01
  • An improved assay by HPLC with amperometric detection for the determination of phentolamine in plasma.  Journal of Liquid Chromatography and Related Technologies.  23:557-564. 2000-01-01
  • Analgesic efficacy and bioavailability of ketorolac in postoperative Pain. A probability analysis.  Archives of Medical Research.  31:191-196. 2000-01-01
  • Activation of adenosine AI receptors facilitates the analgesic effect of ketorolac and ketorolac-caffeine combinations in the rat.  Proceedings of the Western Pharmacology Society.  42:55-58. 1999-01-01
  • Bioavailability of etoposide after oral administration of the solution marketed for intravenous use: Therapeutic and pharmacoeconomic perspectives.  Archives of Medical Research.  30:212-215. 1999-01-01
  • Effect of coadministration of caffeine and either adenosine agonists or cyclic nucleotides on ketorolac analgesia.  European Journal of Pharmacology.  377:175-182. 1999-01-01
  • Limited sampling model for area-under-the-curve monitoring in pediatric patients receiving either Sandimmune® or Neoral® cyclosporin A oral formulations.  Pediatric Transplantation.  3:225-230. 1999-01-01
  • Therapeutic drug monitoring of oxcarbazepine in epileptic patients.  Proceedings of the Western Pharmacology Society.  42:143-. 1999-01-01
  • Bioavailability of two oral formulations of cyclosporin A in uremic children before renal transplantation.  Pediatric Transplantation.  2:145-149. 1998-01-01
  • Caffeine bioavailability after administration with and without non-steroidal anti-inflammatory drugs in rats.  Pharmacy and Pharmacology Communications.  4:451-453. 1998-01-01
  • Characterization of the peripheral mechanism of action involved in the potentiation of the antinociceptive effect of ketorolac by caffeine.  Proceedings of the Western Pharmacology Society.  41:269-. 1998-01-01
  • Determination of indometacin in whole-blood microsamples using HPLC with electrochemical detection [Determinacion de indometacina en micromuestras de sangre empleando clar con deteccion electroquimica].  Revista Mexicana de Ciencias Farmaceuticas.  29:22-25. 1998-01-01
  • Pharmacokinetic evaluation of caffeine-NSAIDs combinations.  Proceedings of the Western Pharmacology Society.  41:274-. 1998-01-01
  • Usefulness of logistic-pharmacokinetic-pharmacodynamic analysis for rational dosing: The case of ketorolac in postoperative pain.  Proceedings of the Western Pharmacology Society.  41:284-. 1998-01-01
  • Oral paracetamol bioavailability in rats subjected to experimental spinal cord injury.  Biopharmaceutics and Drug Disposition.  18:203-211. 1997-01-01
  • Relationship between pharmacokinetics and the antinociceptive effect of indomethacin in the rat.  Proceedings of the Western Pharmacology Society.  40:111-113. 1997-01-01
  • The use of the plasma concentration-effect relationship as a tool for the study of the mechanism of action of naloxone effects on mood and endocrine function.  Journal of Psychopharmacology.  11:361-365. 1997-01-01
  • A new rapid and economical high performance liquid chromatographic assay with electrochemical detection for the determination of etoposide (VP-16) in human plasma samples.  Journal of Liquid Chromatography.  9:939-947. 1996-01-01
  • A new rapid and economical high performance liquid chromatographic assay with electrochemical detection for the determination of etoposide (VP-16) in human plasma samples.  Journal of Liquid Chromatography and Related Technologies.  19:939-947. 1996-01-01
  • Comparison between Sprague-Dawley and Wistar rats as an experimental model of pharmacokinetic alterations induced by spinal cord injury.  Archives of Medical Research.  27:453-457. 1996-01-01
  • Pharmacokinetics of oral ranitidine in Mexicans.  Archives of Medical Research.  27:349-352. 1996-01-01
  • Relationship between blood concentrations and the antinociceptive effect of diclofenac in the rat.  Proceedings of the Western Pharmacology Society.  39:96-. 1996-01-01
  • Relationship between ketorolac pharmacokinetics and analgesic effect in postoperative pain.  Proceedings of the Western Pharmacology Society.  39:99-. 1996-01-01
  • An Experimental Model for the Study of Pharmacokinetic Alterations Induced by Spinal Cord Injury in the Rat.  Pharmacy and Pharmacology Communications.  1:133-135. 1995-01-01
  • Evidence Against the Involvement of Nutritional Habits in the Inter‐ethnic Variability with Regard to Oral Nifedipine Bioavailability.  Pharmacy and Pharmacology Communications.  1:495-497. 1995-01-01
  • Evidence for a postsynaptic action of the serotonergic anxiolytics: Ipsapirone, indorenate and buspirone.  Brain Research Bulletin.  28:497-501. 1992-01-01

• conference paper

  • A population model for tolmetin pharmacokinetics in rats considering saturable elimination.  Proceedings of the Western Pharmacology Society. 135-137. 2001-01-01
• Pharmacokinetic-pharmacodynamic modeling: Why?.  Archives of Medical Research. 539-545. 2000-01-01